Concepedia

Using a novel scoring system for paronychia related to oncologic treatments (<scp>SPOT</scp>) for assessing paronychia severity and its correlation with pain index and quality of life

Po‐Han Ho, I-Chun Lin, X. Yang, Yung‐Tsu Cho, Chia‐Yu Chu

Journal of the European Academy of Dermatology and Venereology · 2018 · 20 citations · 28 references

DOI

Abstract

The SPOT scores demonstrated the association of the paronychia severity with DLQI and pain. It may thus be useful in clinical practice and future studies.

References

28

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Alice P. Chen, Ann Setser, Milan J. Anadkat et al. · Journal of the American Academy of Dermatology · 2012 · 349 citations

, , +10

The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events

Takashi Kawaguchi, Kanako Azuma, Motohiko Sano et al. · Journal of Patient-Reported Outcomes · 2018 · 249 citations · Full text

Multinational Association of Supportive Care in Cancer

Alexandra Kibble · The Lancet Oncology · 2001 · 174 citations

, , +3

Taxane-induced nail changes: incidence, clinical presentationand outcome

Alessandro Marco Minisini, Antonellá Tosti, Alberto Sobrero et al. · Annals of Oncology · 2003 · 169 citations

, , +3

Effects of epidermal growth factor receptor inhibitor‐induced dermatologic toxicities on quality of life

Smita S. Joshi, Sara Ortiz-Toquero, Joslyn N. Witherspoon et al. · Cancer · 2010 · 169 citations · Full text